• Explore /
  • Poster
  • / Phase II trial enzalutamide and androgen deprivation therapy (ADT) with salvage radiation in men with high-risk PSA recurrent prostate cancer (PC): The STREAM trial.

Phase II trial enzalutamide and androgen deprivation therapy (ADT) with salvage radiation in men with high-risk PSA recurrent prostate cancer (PC): The STREAM trial.

Abstract Poster

Authors

Andrew Armstrong

Andrew J. Armstrong

Duke Cancer Institute and the Duke Prostate and Urologic Cancer Center, Durham, NC

Andrew J. Armstrong , Rhonda L. Bitting , Patrick Healy , Daniel J. George , Sung Kim , Tina M. Mayer , Carolyn Winters , Colleen Riggan , Julia Rasmussen , Rhonda Wilder , Monika Anand , Mark N. Stein , Bart Frizzell , Michael Roger Harrison , Tian Zhang , W. Robert Lee , Yuan Wu , Bridget F. Koontz

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer,Prostate Cancer

Sub Track

Prostate Cancer - Localized Disease

Clinical Trial Registration Number

NCT02057939

Citation

J Clin Oncol 37, 2019 (suppl 7S; abstr 29)

DOI

10.1200/JCO.2019.37.7_suppl.29

Abstract #

29

Poster Bd #

B17

Abstract Disclosures

Similar Posters

First Author: Tian Zhang

First Author: Tian Zhang

First Author: Tian Zhang

First Author: Edwin Melencio Posadas